Contribute Try STAT+ Today

After years of anticipation, the Brazilian Supreme Court is holding a hearing this week on a case that has pitted the pharmaceutical industry against consumer advocates over patent rights and the extent to which many prescription drugs are affordable.

At issue is the constitutionality of a provision in the country’s intellectual property law allowing lengthy extensions on patents. Currently, patents are protected for 20 years from the date that an application is filed, as well as another 10 years at the time a patent is granted. Moreover, the government can take 10 years or more to review patent applications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.